Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07279558
PHASE2

Cannabidiol and Alcohol Use Disorder Phenotypes

Sponsor: University of Colorado, Denver

View on ClinicalTrials.gov

Summary

The goal of this study is to learn how CBD affects drinking in people who drink alcohol regularly. Researchers want to see if CBD can help people drink less and reduce problems related to alcohol use.

Official title: Effects of Full-spectrum Cannabidiol on Alcohol Consumption and Alcohol Use Disorder Phenotypes: Implications for Precision Medicine

Key Details

Gender

All

Age Range

21 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

150

Start Date

2026-03-31

Completion Date

2029-08-31

Last Updated

2026-04-03

Healthy Volunteers

No

Interventions

DRUG

Full-Spectrum Cannabidiol (CBD)

Dose: Approximately 200mg of full-spectrum CBD (\<0.3% THC) Active Ingredients: Full spectrum hemp extract Other Ingredients: Hemp seed oil, glycerin, gelatine.

DRUG

Broad-Spectrum Cannabidiol (CBD)

Dose: Approximately 200mg of broad-spectrum CBD, (0% THC) Active Ingredients: Broad spectrum hemp extract Other Ingredients: Hemp seed oil, glycerin, gelatine.

DRUG

Placebo

Active Ingredients: N/A Other Ingredients: Hemp seed oil, glycerin, gelatine.

Locations (1)

University of Colorado School of Medicine- Anschutz Medical Campus

Aurora, Colorado, United States